medicalxpress - People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.
#obesity #healthcare #pharmaceuticals #drugpricing #novonordisk #weightloss #publichealth #biotech
Thursday, November 20, 2025, 1:22 am / permalink 16131 / 6 stories in 3 months
Eli Lilly launches Employer Connect to broaden GLP‑1 coverage (3 days)
GLP‑1 drugs associated with lower addiction risk in large study (4 days)
Novo Nordisk commits $2.1B to Vivtex to pursue oral obesity medicines (8 days)
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.